Celanese Corporation advances robotics opportunities through VIGOR partnership. VIGOR partnership targets robotics applications that may support material innovation but remains peripheral to core chemical operations.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | 2 | — | — | — | — | — | — | — | 3 | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.12 |
—
—
—
|
| 2025 | 0.12 |
—
—
—
—
|
| 2024 | 2.80 |
—
—
—
—
|
| 2023 | 2.80 |
—
—
—
—
|
| 2022 | 2.74 |
—
—
—
—
|
| 2021 | 2.72 |
—
—
—
—
|
| 2020 | 2.48 |
—
—
—
—
|
| 2019 | 2.40 |
—
—
—
—
|
| 2018 | 2.08 |
—
—
—
—
|
| 2017 | 1.74 |
—
—
—
—
|
| 2016 | 1.38 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 1,805.00 | 962.00 | 1,263.00 | 1,364.00 |
| Receivables | 1,784.00 | 1,614.00 | 1,467.00 | 1,869.00 |
| Inventory | 2,357.00 | 2,284.00 | 2,220.00 | 2,305.00 |
| Other | 272.00 | 266.00 | 743.00 | 257.00 |
| 6,218.00 | 5,126.00 | 5,693.00 | 5,795.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,510.00 | 1,228.00 | 1,279.00 | 1,485.00 |
| ST’ Debt | 1,383.00 | 1,501.00 | 1,204.00 | 1,311.00 |
| Other | 1,154.00 | 1,157.00 | 1,124.00 | 1,106.00 |
| 4,072.00 | 3,890.00 | 3,683.00 | 4,006.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,337.00 | 2,752.00 | — | — |
—
|
| ’25 | 2,389.00 | 2,532.00 | 2,419.00 | 2,204.00 |
9,544.00
|
| ’24 | 2,611.00 | 2,651.00 | 2,648.00 | 2,358.00 |
10,268.00
|
| ’23 | 2,853.00 | 2,795.00 | 2,723.00 | 2,555.00 |
10,926.00
|
| ’22 | 2,538.00 | 2,486.00 | 2,301.00 | 2,348.00 |
9,673.00
|
| ’21 | 1,798.00 | 2,198.00 | 2,266.00 | 2,275.00 |
8,537.00
|
| ’20 | 1,460.00 | 1,193.00 | 1,411.00 | 1,591.00 |
5,655.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 76.00 | 209.00 | — | — |
—
|
| ’25 | 37.00 | 410.00 | 447.00 | 252.00 |
1,146.00
|
| ’24 | 101.00 | 292.00 | 79.00 | 494.00 |
966.00
|
| ’23 | (96.00) | 762.00 | 403.00 | 830.00 |
1,899.00
|
| ’22 | 316.00 | 495.00 | 467.00 | 541.00 |
1,819.00
|
| ’21 | 116.00 | 427.00 | 630.00 | 584.00 |
1,757.00
|
| ’20 | 259.00 | 379.00 | 431.00 | 274.00 |
1,343.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 10.00 | 147.00 | — | — |
—
|
| ’25 | (65.00) | 317.00 | 383.00 | 168.00 |
803.00
|
| ’24 | (36.00) | 187.00 | (9.00) | 389.00 |
531.00
|
| ’23 | (260.00) | 617.00 | 272.00 | 702.00 |
1,331.00
|
| ’22 | 179.00 | 371.00 | 328.00 | 398.00 |
1,276.00
|
| ’21 | 24.00 | 317.00 | 528.00 | 421.00 |
1,290.00
|
| ’20 | 140.00 | 291.00 | 359.00 | 189.00 |
979.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.40 | 1.13 | — | — |
—
|
| ’25 | (0.19) | 1.81 | (12.39) | 0.17 |
(10.64)
|
| ’24 | 1.10 | 1.41 | 1.06 | (17.50) |
(13.93)
|
| ’23 | 0.83 | 2.01 | 8.69 | 6.37 |
17.92
|
| ’22 | 4.61 | 3.98 | 1.75 | 7.03 |
17.34
|
| ’21 | 2.82 | 4.77 | 4.56 | 4.79 |
16.86
|
| ’20 | 1.82 | 0.90 | 1.75 | 12.50 |
16.75
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 86.71 | 97.12 | 66.73 | 35.13 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 176.50 | 159.06 | 172.16 | 75.84 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,263 | 12,410 | 12,163 | 11,434 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.73 | 0.88 | 0.84 | 0.83 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,673.00 | 10,926.00 | 10,268.00 | 9,544.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.60% | 23.64% | 22.75% | 20.45% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,421.00 | 1,161.00 | (1,019.00) | (1,220.00) | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.69% | 10.63% | (9.92%) | (12.78%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,902.00 | 1,947.00 | (1,534.00) | (1,151.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 478.00 | 739.00 | 823.00 | 786.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 89.25 | 100.38 | 93.97 | 87.14 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.48 | 18.01 | (13.93) | (10.64) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.78 | 17.45 | 8.84 | 10.46 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.01) | (5.22) | (3.98) | (3.13) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.77 | 12.23 | 4.86 | 7.33 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.33 | 69.38 | 50.91 | 40.83 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 108.38 | 108.85 | 109.27 | 109.53 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.85 | 8.60 | 0.00 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.15 | 1.54 | 0.74 | 0.49 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 1.82 | 2.23 | 1.36 | 1.04 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.51 | 2.63 | 1.87 | 1.67 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.01 | 21.58 | 36.12 | 19.88 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,819.00 | 1,899.00 | 966.00 | 1,146.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (543.00) | (568.00) | (435.00) | (343.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,276.00 | 1,331.00 | 531.00 | 803.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,543.00 | 2,146.00 | 1,236.00 | 2,010.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,679.00 | 13,684.00 | 12,579.00 | 12,598.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,171.00 | 11,879.00 | 11,617.00 | 11,335.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,105.00 | 7,552.00 | 5,563.00 | 4,472.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.90% | 7.35% | (6.24%) | (5.23%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.47% | 5.36% | (2.62%) | (3.11%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.59% | 28.45% | (23.52%) | (23.22%) | ‡‡‡‡‡ | — | — |
ROE
|
Celanese Corporation (CE), a specialty chemicals giant, has navigated a turbulent decade marked by aggressive expansion, the transformative 2022 DuPont acquisition that diversified revenues but spiked debt to $14.7 billion, and 2024’s sharp profitability plunge amid high interest rates, softening demand, and commodity deflation. Revenue peaked at $10.94 billion in 2023 before a 6% drop to $10.28 billion last year, with gross margins eroding to 22.9% and massive losses including a $996 million EBT deficit and -13.93 EPS, driven by inventory writedowns and weak acetyl pricing—highlighting the sector’s cyclical sensitivity to inputs like ethylene and autos/China slowdowns.
Yet, glimmers of recovery shine through: analysts project revenue stabilization around $9.6 billion in 2025-2026 before a 3% rebound to $9.86 billion in 2027, with profitability swinging dramatically to $1.63 billion EBT in 2025 and positive EPS by 2026. Insider confidence is striking, with $1.49 million in 2025 buys by executives and directors (no sells), signaling optimism on cost cuts and cycle upturns. Free cash flow remains resilient at $4.86 per share despite capex, supporting a ~3-4% yield.
Trading near $59 after a 62% peak-to-trough drop, CE’s 0.74x P/S and 1.36x P/B scream undervaluation versus historical norms, though analyst mean targets imply 15% downside (high offers 46% upside). With EV battery exposure from DuPont positioning for electrification tailwinds and potential margin repair to 25%+, this cycle-bottom play backed by insiders could rerate 30-50%—if macro risks like recession or prolonged China weakness are navigated.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.